Eli Lilly’s obesity pill led to around 12% weight loss in closely watched late-stage trial; shares drop – CNBC By Weight Loss Eli Lilly’s obesity pill led to around 12% weight loss in closely watched late-stage trial; shares drop CNBC Pill Causes Major Weight Loss in Eli Lilly Trial’s Results The New York Times Lilly raises full-year earnings forecasts on surging demand for weight-loss drug Reuters Brought to you by Google News. Read the rest of the article here. Facebook Twitter Pinterest